Bayzed Health Group Inc. filed its Monthly Return for Equity Issuers (Form FF301) with Hong Kong Exchanges and Clearing Limited on 3 September 2026, covering movements in its securities for the month ended 31 August 2026.
Authorised and Issued Share Capital • Authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equating to USD 50,000. No adjustments were recorded during the month. • Issued share count was unchanged at 1.32 billion ordinary shares. The company held no treasury shares, matching the position at the end of July 2026.
Public Float Compliance Bayzed Health confirmed that it met the Main Board’s Initial Prescribed Threshold, maintaining at least 25% of its issued shares in public hands as of 31 August 2026.
Equity Incentive Schemes and Other Instruments • Post-IPO Share Option Scheme (adopted 8 August 2023; amended 9 June 2025): no options were outstanding, granted, exercised, or lapsed during the month. • The report recorded zero warrants, convertibles, or other share-linked instruments, and no other arrangements to issue shares. • Aggregate increases in issued shares and changes in treasury shares during August 2026 were both nil.
Regulatory Confirmations Management affirmed compliance with all applicable Hong Kong Listing Rules and regulatory requirements, stating that no new securities were issued, and no treasury shares were transferred or sold in August 2026.
The filing underscores Bayzed Health’s stable capital structure and adherence to Hong Kong Stock Exchange listing obligations for the reporting period.
Comments